Clinical Trial Update: Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic Cyclophosphamide [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of weekly trabectedin combined with metronomic cyclophosphamide in soft-tissue sarcoma; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Trabectedin (trabectedin)

Snippet

Sponsor: Institut Bergonié | Conditions: Soft-tissue Sarcomas | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-03-23